litlas
ログインアカウント作成

Michel Delforge

1995–2025 年に発表

106
論文数
19,655
被引用数
60
h 指数
98
i10 指数

被引用数

Michel Delforge の年別被引用数1988 年: 被引用 2 件1989 年: 被引用 1 件1990 年: 被引用 1 件1997 年: 被引用 4 件1998 年: 被引用 1 件1999 年: 被引用 1 件2000 年: 被引用 2 件2001 年: 被引用 1 件2002 年: 被引用 1 件2003 年: 被引用 2 件2004 年: 被引用 2 件2005 年: 被引用 1 件2006 年: 被引用 2 件2008 年: 被引用 3 件2009 年: 被引用 13 件2010 年: 被引用 18 件2011 年: 被引用 52 件2012 年: 被引用 71 件2013 年: 被引用 91 件2014 年: 被引用 98 件2015 年: 被引用 99 件2016 年: 被引用 137 件2017 年: 被引用 129 件2018 年: 被引用 109 件2019 年: 被引用 490 件2020 年: 被引用 620 件2021 年: 被引用 790 件2022 年: 被引用 822 件2023 年: 被引用 795 件2024 年: 被引用 1,466 件2025 年: 被引用 723 件2026 年: 被引用 11 件1991〜1996 年は被引用が無いため表示していません2007 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,049 件、この内訳の 23.1%ドイツ: 引用元論文 617 件、この内訳の 7%中国: 引用元論文 583 件、この内訳の 6.6%イタリア: 引用元論文 500 件、この内訳の 5.6%フランス: 引用元論文 484 件、この内訳の 5.5%イギリス: 引用元論文 462 件、この内訳の 5.2%スペイン: 引用元論文 445 件、この内訳の 5%オランダ: 引用元論文 332 件、この内訳の 3.8%カナダ: 引用元論文 298 件、この内訳の 3.4%ギリシャ: 引用元論文 267 件、この内訳の 3%ベルギー: 引用元論文 259 件、この内訳の 2.9%オーストラリア: 引用元論文 208 件、この内訳の 2.4%
0%23.1%その他 26.5%

機関

分野

  • Medicine78.2%
  • Biochemistry, Genetics and Molecular Biology10%
  • Immunology and Microbiology10%
  • Computer Science0.3%
  • Economics, Econometrics and Finance0.2%
  • Neuroscience0.2%
  • その他1.1%

トピック

  • Multiple Myeloma Research and Treatments15.9%
  • CAR-T cell therapy research9.8%
  • Protein Degradation and Inhibitors7.4%
  • Peptidase Inhibition and Analysis4.1%
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms2.9%
  • Cancer Treatment and Pharmacology2.6%
  • その他57.3%

共著者

全論文

検索で開く
  1. Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

    著者: Nikhil C. Munshi, Larry D. Anderson, Nina Shah, Deepu Madduri, Jesús G. Berdeja, Sagar Lonial, Noopur Raje, Yi Lin, David S. Siegel, Albert Oriol, Philippe Moreau, Ibrahim Yakoub‐Agha, Michel Delforge, Michèle Cavo, Hermann Einsele, Hartmut Goldschmidt, Katja Weisel, Alessandro Rambaldi, Donna Reece, Fabio Petrocca, Monica Massaro, Jamie N. Connarn, Shari M. Kaiser, Payal Patel, Liping Huang, Timothy Campbell, Kristen Hege, Jesús F. San Miguel - New England Journal of Medicine 2021 被引用: 2,424

  2. Teclistamab in Relapsed or Refractory Multiple Myeloma

    著者: Philippe Moreau, Alfred L. Garfall, Niels W.C.J. van de Donk, Hareth Nahi, Jesús F. San Miguel, Albert Oriol, Ajay K. Nooka, Thomas G. Martin, Laura Rosiñol, Ajai Chari, Lionel Karlin, Lotfi Benboubker, María‐Victoria Mateos, Nizar J. Bahlis, Rakesh Popat, Britta Besemer, Joaquín Martínez‐López, Surbhi Sidana, Michel Delforge, Lixia Pei, Danielle Trancucci, Raluca Verona, Suzette Girgis, Shun Xin Wang Lin, Yunsi Olyslager, Mindy Jaffe, Clarissa Uhlar, Tara Stephenson, Rian Van Rampelbergh, Arnob Banerjee, Jenna D. Goldberg, Rachel Kobos, Amrita Krishnan, Saad Z. Usmani - New England Journal of Medicine 2022 被引用: 1,114

  3. Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma

    著者: Paula Rodríguez‐Otero, Sikander Ailawadhi, Bertrand Arnulf, Krina K. Patel, Michèle Cavo, Ajay K. Nooka, Salomon Manier, Natalie S. Callander, Luciano J. Costa, Ravi Vij, Nizar J. Bahlis, Philippe Moreau, Scott R. Solomon, Michel Delforge, Jesús G. Berdeja, Anna Truppel-Hartmann, Zhihong Yang, Linda Favre‐Kontula, Fan Wu, Julia Piasecki, Mark Cook, Sergio Giralt - New England Journal of Medicine 2023 被引用: 705

  4. Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

    著者: Pieter Sonneveld, Meletios Α. Dimopoulos, Mario Boccadoro, Hang Quach, P. Joy Ho, Meral Beksaç, Cyrille Hulin, Elisabetta Antonioli, Xavier Leleu, Silvia Mangiacavalli, Aurore Perrot, Michèle Cavo, Angelo Belotti, Annemiek Broijl, Francesca Gay, Roberto Mina, Inger S. Nijhof, Niels W.C.J. van de Donk, Eirini Katodritou, Fredrik Schjesvold, Anna Sureda, Laura Rosiñol, Michel Delforge, Wilfried Roeloffzen, Tobias Silzle, Annette Juul Vangsted, Hermann Einsele, Andrew Spencer, Roman Hájek, Artur Jurczyszyn, Sarah Lonergan, Tahamtan Ahmadi, Yanfang Liu, Jianping Wang, Diego Vieyra, Emilie M.J. van Brummelen, Véronique Vanquickelberghe, Anna Sitthi-Amorn, Carla J. de Boer, Robin Carson, Paula Rodríguez‐Otero, Joan Bladé, Philippe Moreau - New England Journal of Medicine 2023 被引用: 515

  5. Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up.

    著者: Meletios Α. Dimopoulos, Philippe Moreau, Evangelos Terpos, María‐Victoria Mateos, Sonja Zweegman, Gordon Cook, Michel Delforge, Roman Hájek, Fredrik Schjesvold, Michèle Cavo, Hartmut Goldschmidt, Thierry Façon, Hermann Einsele, Mario Boccadoro, Jesús F. San Miguel, Pieter Sonneveld, Ulrich Mey - Annals of Oncology 2021 被引用: 820

  6. Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

    著者: Philippe Moreau, Michel Attal, Cyrille Hulin, Bertrand Arnulf, Karim Belhadj, Lotfi Benboubker, Marie C. Béné, Annemiek Broijl, Hélène Caillon, Denis Caillot, Jill Corre, Michel Delforge, Thomas Dejoie, Chantal Doyen, Thierry Façon, Cécile Sonntag, Jean Fontan, Laurent Garderet, Kon‐Siong G. Jie, Lionel Karlin, Frédérique Kuhnowski, Jérôme Lambert, Xavier Leleu, Pascal Lenain, Margaret Macro, Claire Mathiot, Frédérique Orsini‐Piocelle, Aurore Perrot, Anne‐Marie Stoppa, Niels W.C.J. van de Donk, Soraya Wuillème, Sonja Zweegman, Brigitte Kolb, Cyrille Touzeau, Murielle Roussel, Mourad Tiab, Jean‐Pierre Marolleau, Nathalie Meuleman, Marie‐Christiane Vekemans, Matthijs Westerman, Saskia K. Klein, Mark‐David Levin, Jean Paul Fermand, Martine Escoffre‐Barbe, Jean‐Richard Eveillard, Réda Garidi, Tahamtan Ahmadi, Sen Hong Zhuang, Christopher Chiu, Lixia Pei, Carla de Boer, Elena Smith, William Deraedt, Tobias Kampfenkel, Jordan M. Schecter, Jessica Vermeulen, Hervé Avet‐Loiseau, Pieter Sonneveld - The Lancet 2019 被引用: 953

  7. Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network

    著者: Heinz Ludwig, Evangelos Terpos, Niels W.C.J. van de Donk, María‐Victoria Mateos, Philippe Moreau, Melitios-Athanasios Dimopoulos, Michel Delforge, Paula Rodríguez‐Otero, Jesús F. San Miguel, Kwee Yong, Francesca Gay, Hermann Einsele, Roberto Mina, Jo Caers, Christoph Driessen, Pellegrino Musto, Sonja Zweegman, Monika Engelhardt, Gordon Cook, Katja Weisel, Annemiek Broijl, Meral Beksaç, Jelena Bila, Fredrik Schjesvold, Michèle Cavo, Roman Hájek, Cyrille Touzeau, Mario Boccadoro, Pieter Sonneveld - The Lancet Oncology 2023 被引用: 178

  8. LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma

    著者: María‐Victoria Mateos, Katja Weisel, Valerio De Stefano, Hartmut Goldschmidt, Michel Delforge, Mohamad Mohty, Michèle Cavo, Ravi Vij, Joanne Lindsey-Hill, Dominik Dytfeld, Emanuele Angelucci, Aurore Perrot, Reuben Benjamin, Niels W.C.J. van de Donk, Enrique M. Ocio, Christof Scheid, Francesca Gay, Wilfried Roeloffzen, Paula Rodríguez‐Otero, Annemiek Broijl, Anna Potamianou, Caline Sakabedoyan, Maria Semerjian, Sofia Keim, Vadim Strulev, Jordan M. Schecter, Martin Vogel, Robert Wapenaar, Tonia Nesheiwat, Jesús F. San Miguel, Pieter Sonneveld, Hermann Einsele, Philippe Moreau - Leukemia 2022 被引用: 240

  9. Neutrophil extracellular trap cell death requires both autophagy and superoxide generation

    著者: Quinten Remijsen, Tom Vanden Berghe, Ellen Wirawan, Bob Asselbergh, Eef Parthoens, Riet De Rycke, Sam Noppen, Michel Delforge, Jean Willems, Peter Vandenabeele - Cell Research 2010 被引用: 806

  10. Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

    著者: Michel Attal, Paul G. Richardson, S. Vincent Rajkumar, Jesús F. San Miguel, Meral Beksaç, Ivan Špıčka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios Α. Dimopoulos, Jeffrey Shang-Yi Huang, Jiří Minařík, Michèle Cavo, H. Miles Prince, Sandrine Macé, Kathryn P. Corzo, Frank Campana, Solenn Le-Guennec, Franck Dubin, Kenneth C. Anderson, Michel Attal, Paul G. Richardson, S. Vincent Rajkumar, Jesús F. San Miguel, Meral Beksaç, Ivan Špıčka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios Α. Dimopoulos, Jeffrey Shang-Yi Huang, Jiří Minařík, Michèle Cavo, H. Miles Prince, Sandrine Macé, Kathryn P. Corzo, Frank Campana, Solenn Le-Guennec, Franck Dubin, Kenneth C. Anderson, Simon J. Harrison, Wojciech Janowski, Ian Kerridge, Andrew Spencer, Michel Delforge, Karel Fostier, Philip Vlummens, Ka Lung Wu, Richard LeBlanc, Michel Pavic, Michaël Sébag, Roman Hájek, Vladimír Maisnar, Luděk Pour, Henrik Gregersen, Lotfi Benbouker, Denis Caillot, Martine Escoffre‐Barbe, Thierry Façon, Laurent Frenzel, Cyrille Hulin, Lionel Karlin, Brigitte Kolb, Brigitte Pegourié, Aurore Perrot, Mourad Tiab, Laure Vincent, Dietger Niederwieser, Αchilles Anagnostopoulos, Sosana Delimpasi, Marie‐Christine Kyrtsonis, Anargyros Symeonidis, Árpád Illés, Gábor Mikala, Zsolt Nagy, Sara Bringen, Paolo Corradini, Fabio Ciceri, Roberto M. Lemoli, Anna Marina Liberati, Chiara Nozzoli, Renato Zambello, Shinsuke Iida, Takashi Ikeda, Satoshi Iyama, Morio Matsumoto, Chihiro Shimazaki, Kazutaka Sunami, Kenshi Suzuki, Michihiro Uchiyama, Youngil Koh, Kihyun Kım, Jae Hoon Lee, Chang‐Ki Min, Hillary Blacklock, Hugh J. B. Goodman, Annette Neylon, David Simpson, Sebastian Grosicki, Artur Jurczyszyn ほか 30 名 - The Lancet 2019 被引用: 636

  11. Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

    著者: Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou, Ajay K. Nooka, Andrew J. Yee, Carol Ann Huff, Philippe Moreau, David Dingli, Craig E. Cole, Sagar Lonial, Meletios Α. Dimopoulos, A. Keith Stewart, Joshua Richter, Ravi Vij, Sascha A. Tuchman, Marc S. Raab, Katja Weisel, Michel Delforge, Robert F. Cornell, David Kaminetzky, James E. Hoffman, Luciano J. Costa, Terri L. Parker, Moshe Levy, Martin Schreder, Nathalie Meuleman, Laurent Frenzel, Mohamad Mohty, Sylvain Choquet, Gary J. Schiller, Raymond L. Comenzo, Monika Engelhardt, Thomas Illmer, Philip Vlummens, Chantal Doyen, Thierry Façon, Lionel Karlin, Aurore Perrot, Klaus Podar, Michael Kauffman, Sharon Shacham, Lingling Li, Shijie Tang, Carla Picklesimer, Jean‐Richard Saint‐Martin, Marsha Crochiere, Hua Chang, Samir Parekh, Yosef Landesman, Jatin J. Shah, Paul G. Richardson, Sundar Jagannath - New England Journal of Medicine 2019 被引用: 673

  12. Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial

    著者: Philippe Moreau, Cyrille Hulin, Aurore Perrot, Bertrand Arnulf, Karim Belhadj, Lotfi Benboubker, Marie C. Béné, Sonja Zweegman, Hélène Caillon, Denis Caillot, Jill Corre, Michel Delforge, Thomas Dejoie, Chantal Doyen, Thierry Façon, Cécile Sonntag, Jean Fontan, Mohamad Mohty, Kon‐Siong G. Jie, Lionel Karlin, Frédérique Kuhnowski, Jérôme Lambert, Xavier Leleu, Margaret Macro, Frédérique Orsini-Piocelle, Murielle Roussel, Anne‐Marie Stoppa, Niels W.C.J. van de Donk, Soraya Wuillème, Annemiek Broijl, Cyrille Touzeau, Mourad Tiab, Jean‐Pierre Marolleau, Nathalie Meuleman, Marie‐Christiane Vekemans, Matthijs Westerman, Saskia K. Klein, Mark‐David Levin, Fritz Offner, Martine Escoffre‐Barbe, Jean‐Richard Eveillard, Réda Garidi, Tahamtan Ahmadi, Maria Krevvata, Ke Zhang, Carla de Boer, Sanjay Vara, Tobias Kampfenkel, Véronique Vanquickelberghe, Jessica Vermeulen, Hervé Avet‐Loiseau, Pieter Sonneveld - The Lancet Oncology 2021 被引用: 175

  13. Long-term follow-up from MajesTEC-1 of teclistamab, a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM).

    著者: Niels W.C.J. van de Donk, Philippe Moreau, Alfred L. Garfall, Manisha Bhutani, Albert Oriol, Ajay K. Nooka, Thomas G. Martin, Laura Rosiñol, María‐Victoria Mateos, Nizar J. Bahlis, Rakesh Popat, Britta Besemer, Joaquín Martínez‐López, Amrita Krishnan, Michel Delforge, Danielle Trancucci, Raluca Verona, Tara Stephenson, Katherine Chastain, Surbhi Sidana - Journal of Clinical Oncology 2023 被引用: 65

  14. Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial

    著者: Jesús F. San Miguel, Katja Weisel, Philippe Moreau, Martha Q. Lacy, Kevin Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Anne Banos, Albert Oriol, Adrían Alegre, Christine Chen, Michèle Cavo, Laurent Garderet, Valentina Ivanova, Joaquín Martínez‐López, Andrew R. Belch, Antonio Palumbo, Stephen Schey, Pieter Sonneveld, Xin Yu, Lars Sternås, Christian Jacques, Mohamed H. Zaki, Meletios Α. Dimopoulos - The Lancet Oncology 2013 被引用: 799

  15. Long-term follow-up from the phase 1/2 MajesTEC-1 trial of teclistamab in patients with relapsed/refractory multiple myeloma.

    著者: Alfred L. Garfall, Ajay K. Nooka, Niels W.C.J. van de Donk, Philippe Moreau, Manisha Bhutani, Albert Oriol, Thomas G Martin, Laura Rosiñol, María‐Victoria Mateos, Nizar J. Bahlis, Rakesh Popat, Britta Besemer, Joaquín Martínez‐López, Amrita Krishnan, Michel Delforge, Lin Huang, Deeksha Vishwamitra, Tara Stephenson, Katherine Chastain, Surbhi Sidana - Journal of Clinical Oncology 2024 被引用: 77

  16. Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma

    著者: Lotfi Benboubker, Meletios Α. Dimopoulos, Angela Dispenzieri, John Catalano, Andrew R. Belch, Michèle Cavo, Antonello Pinto, Katja Weisel, Heinz Ludwig, Nizar J. Bahlis, Anne Banos, Mourad Tiab, Michel Delforge, Jamie Cavenagh, Catarina Geraldes, Je‐Jung Lee, Christine Chen, Albert Oriol, Javier de la Rubia, Lugui Qiu, Darrell White, Daniel Binder, Kenneth Anderson, Jean-Paul Fermand, Philippe Moreau, Michel Attal, Robert Knight, Guang Chen, Jason Van Oostendorp, Christian Jacques, Annette Ervin‐Haynes, Hervé Avet‐Loiseau, Cyrille Hulin, Thierry Façon - New England Journal of Medicine 2014 被引用: 786

  17. Multiple myeloma: patient outcomes in real‐world practice

    著者: Kwee Yong, Michel Delforge, Christoph Driessen, Leah Fink, Alain Flinois, Sebastian Gonzalez‐McQuire, Reza Safaei, Lionel Karlin, María‐Victoria Mateos, Marc S. Raab, Paul Schoen, Michèle Cavo - British Journal of Haematology 2016 被引用: 321

  18. Echo Parameters for Differential Diagnosis in Cardiac Amyloidosis

    著者: Efstathios D. Pagourelias, Oana Mirea, Jürgen Duchenne, Johan Van Cleemput, Michel Delforge, Jan Bogaert, Tatiana Kuznetsova, Jens‐Uwe Voigt - Circulation Cardiovascular Imaging 2017 被引用: 298

  19. Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

    著者: Shaji Kumar, Meletios Α. Dimopoulos, Efstathios Kastritis, Evangelos Terpos, Hareth Nahi, Hartmut Goldschmidt, Jens Hillengaß, Xavier Leleu, Meral Beksaç, Melissa Alsina, Albert Oriol, Michèle Cavo, Enrique M. Ocio, María‐Victoria Mateos, Elizabeth O’Donnell, Ravi Vij, H M Lokhorst, Niels W.C.J. van de Donk, Chang‐Ki Min, Tomer M. Mark, Ingemar Turesson, Markus Hansson, Heinz Ludwig, Sundar Jagannath, Michel Delforge, Charalampia Kyriakou, Parameswaran Hari, Ulf‐Henrik Mellqvist, Saad Z. Usmani, Dominik Dytfeld, Ashraf Badros, Philippe Moreau, K Kim, P R Otero, J H Lee, Chaim Shustik, Daniel D. Waller, Wee Joo Chng, Shuji Ozaki, J-J Lee, Javier de la Rubia, Hyeon‐Seok Eom, Laura Rosiñol, Juan José Lahuerta, Anna Sureda, Jin Seok Kim, B G M Durie - Leukemia 2017 被引用: 354

  20. Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial

    著者: Philippe Moreau, Cyrille Hulin, Aurore Perrot, Bertrand Arnulf, Karim Belhadj, Lotfi Benboubker, Sonja Zweegman, Hélène Caillon, Denis Caillot, Hervé Avet‐Loiseau, Michel Delforge, Thomas Dejoie, Thierry Façon, Cécile Sonntag, Jean Fontan, Mohamad Mohty, Kon‐Siong G. Jie, Lionel Karlin, Frédérique Kuhnowski, Jérôme Lambert, Xavier Leleu, Margaret Macro, Frédérique Orsini‐Piocelle, Murielle Roussel, Jean Marc Schiano de Colella, Niels W.C.J. van de Donk, Soraya Wuillème, Annemiek Broijl, Cyrille Touzeau, Mourad Tiab, Jean‐Pierre Marolleau, Nathalie Meuleman, Marie‐Christiane Vekemans, Matthijs Westerman, Saskia K. Klein, Mark‐David Levin, Fritz Offner, Martine Escoffre‐Barbe, Jean‐Richard Eveillard, Réda Garidi, Winnie Hua, Jianping Wang, Alba Tuozzo, Carla de Boer, Melissa Rowe, Véronique Vanquickelberghe, Robin Carson, Jessica Vermeulen, Jill Corre, Pieter Sonneveld - The Lancet Oncology 2024 被引用: 112

  21. Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT

    著者: Nico Gagelmann, Diderik-Jan Eikema, Simona Iacobelli, Linda Köster, Hareth Nahi, Anne‐Marie Stoppa, Tamás Masszi, Denis Caillot, Stig Lenhoff, Miklós Udvardy, Charles Crawley, William Arcese, Clara Mariette, Ann Hunter, Xavier Leleu, Martin R. Schipperus, Michel Delforge, Pietro Pioltelli, John A. Snowden, Maija Itälä‐Remes, Maurizio Musso, Anja van Biezen, Laurent Garderet, Nicolaus Kröger - Haematologica 2018 被引用: 112

  22. CAMMA 2: A phase I/II trial evaluating the efficacy and safety of cevostamab in patients with relapsed/refractory multiple myeloma (RRMM) who have triple-class refractory disease and have received a prior anti-B-cell maturation antigen (BCMA) agent.

    著者: Shaji Kumar, Carlos Bachier, Michèle Cavo, Paolo Corradini, Michel Delforge, Wojciech Janowski, Alexander M. Lesokhin, Roberto Mina, Laura París, Laura Rosiñol, Hang Quach, Grant R. Goodman, Rin Nakamura, Divya Samineni, Vallari Shah, Elisabeth Wassner Fritsch, Jesús G. Berdeja - Journal of Clinical Oncology 2023 被引用: 40

  23. Ide-cel vs standard regimens in triple-class–exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses

    著者: Sikander Ailawadhi, Bertrand Arnulf, Krina K. Patel, Michèle Cavo, Ajay K. Nooka, Salomon Manier, Natalie S. Callander, Luciano J. Costa, Ravi Vij, Nizar J. Bahlis, Philippe Moreau, Scott R. Solomon, Ingerid Weum Abrahamsen, Rachid Baz, Annemiek Broijl, Christine Chen, Sundar Jagannath, Noopur Raje, Christof Scheid, Michel Delforge, Reuben Benjamin, Thomas Pabst, Shinsuke Iida, Jesús G. Berdeja, Sergio Giralt, Anna Truppel-Hartmann, Yanping Chen, Xiaobo Zhong, Fan Wu, Julia Piasecki, Laurie Eliason, Devender Dhanda, Jasper Felten, Andrea Caia, Mark Cook, Mihaela Popa-McKiver, Paula Rodríguez‐Otero - Blood 2024 被引用: 63

  24. Idecabtagene vicleucel (ide-cel, bb2121), a BCMA-directed CAR T cell therapy, in relapsed and refractory multiple myeloma: Updated KarMMa results.

    著者: Larry D. Anderson, Nikhil C. Munshi, Nina Shah, Sundar Jagannath, Jesús G. Berdeja, Sagar Lonial, Noopur Raje, David S. Siegel, Yi Lin, Albert Oriol, Philippe Moreau, Ibrahim Yakoub‐Agha, Michel Delforge, Fabio Petrocca, Payal Patel, Liping Huang, Timothy Campbell, Kristen Hege, Jesús F. San Miguel, on behalf of the KarMMa Study Investigators - Journal of Clinical Oncology 2021 被引用: 66